6-31667889-G-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001320.7(CSNK2B):c.94G>T(p.Asp32Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D32H) has been classified as Pathogenic.
Frequency
Consequence
NM_001320.7 missense
Scores
Clinical Significance
Conservation
Publications
- Poirier-Bienvenu neurodevelopmental syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Illumina, Labcorp Genetics (formerly Invitae), G2P
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001320.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CSNK2B | NM_001320.7 | MANE Select | c.94G>T | p.Asp32Tyr | missense | Exon 3 of 7 | NP_001311.3 | ||
| CSNK2B | NM_001282385.2 | c.94G>T | p.Asp32Tyr | missense | Exon 3 of 7 | NP_001269314.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CSNK2B | ENST00000375882.7 | TSL:1 MANE Select | c.94G>T | p.Asp32Tyr | missense | Exon 3 of 7 | ENSP00000365042.3 | ||
| ENSG00000263020 | ENST00000617558.2 | TSL:1 | c.94G>T | p.Asp32Tyr | missense | Exon 2 of 6 | ENSP00000483989.2 | ||
| ENSG00000263020 | ENST00000375880.6 | TSL:3 | c.94G>T | p.Asp32Tyr | missense | Exon 3 of 8 | ENSP00000365040.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Poirier-Bienvenu neurodevelopmental syndrome Pathogenic:2
The variant is not observed in the gnomAD v4.0.0 dataset. Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.84 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.94 (>=0.6, sensitivity 0.72 and precision 0.9)]. The same nucleotide change resulting in the same amino acid change has been previously reported to be associated with CSNK2B-related disorder (ClinVar ID: VCV001685680 /PMID: 34983633). The variant has been previously reported as de novo in a similarly affected individual (PMID: 34983633). Different missense changes at the same codon (p.Asp32Ala, p.Asp32Asn, p.Asp32His) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000520596, VCV003024534 /PMID: 33644862, 35571680). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34983633)
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at